Shares of telemedicine specialist Teladoc Health (NYSE: TDOC) won a rare buy rating on Wall Street today when Argus Research announced it was upgrading the shares from hold to buy -- and assigning the company a $95 price target that implies 36% upside from today's prices.
So, naturally, Teladoc stock dropped 4.3% through 1 p.m. ET today... ?
Image source: Getty Images.
Source Fool.com